Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
medicare
5
×
tc
united states
autoimmune diseases
biotech
biotech ipos
boston blog main
boston top stories
clinical trials
column
ec column
finance
health
immunotherapy
investing
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
venture capital
8vc
abeona therapeutics
accent therapeutics
achilles therapeutics
acute myeloid leukemia
addepar
advisors
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
alpha
alx oncology
amarin
amgen
What
market
5
×
new
business
industry
advantages
americans
arrival
attract
bar
better
bio
biotech
brings
capital
christensen
chronic
clayton
clumsy
commerce
companies
conditions
customer
days
demanding
disruptors
drug
end
expect
experiences
gamble
getting
growing
harvard
hasn’t
health
hold
home
ignored
insurtech
investment
Language
unset
5
×
Current search:
medicare
×
unset
×
market
×
@techcrunch.com
1 year ago
Can Medicare save the insurtech market?
@techcrunch.com
2 years ago
What are the ‘jobs to be done’ of an investment manager?
@techcrunch.com
3 years ago
Better Health raises $3.5M seed round to reinvent medical supply shopping through e-commerce
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone